about
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinomaNew loci associated with chronic hepatitis B virus infection in Han ChineseDLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaTumor suppressor and hepatocellular carcinomaGenome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, ChinaNCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinomaSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasMolecular genetics of hepatocellular neoplasia.Keratin 18 phosphorylation as a progression marker of chronic hepatitis B.Hepatitis B virus-induced oncogenesis.Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinomaCorrelation of p53 gene mutation and expression of P53 protein in cholangiocarcinomaSAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma.Cancer gene discovery in hepatocellular carcinomaHepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in miceInherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese populationEstablishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivoPromoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma.Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines.Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinomap53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth.TP53 mutations in workers exposed to occupational carcinogens.Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.Regulation of apoptosis by the circadian clock through NF-kappaB signaling.Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysisRb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression.Mutant p53: one name, many proteins.Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detectionSuppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signalingClinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities.Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.Actin and Vimentin proteins with N-terminal deletion detected in tumor-bearing rat livers induced by intraportal-vein injection of Ha-ras-transfected rat liver cellsIn vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B.Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patientsPrognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma.
P2860
Q28239503-62FDDDD5-5868-4354-84B5-E5E61C745A08Q28300932-28D7FD0A-7C32-49A0-A543-23B1D1F57E49Q28384558-5B0B0E81-CDF5-46C7-844A-9BFD99EB113CQ28389231-C1D30A90-5D8B-4908-B613-521F9ED6A585Q28538135-07435491-2F34-4036-BB92-607C82BE128BQ28586911-ADB6D89A-4695-436A-9D53-91AFE8AF7A22Q29616243-F3B4B86E-C48D-43E1-A8B4-4C8788B8FB4AQ33680701-F06398DB-841B-4ECC-96A3-BD1EBDB94B0FQ33784854-B22BB7D3-6C9C-4E0C-9348-3D6EAA8859CFQ33787553-27E69877-12C1-4903-A358-75992A8A11FCQ33797504-90580C5E-AE4F-4E40-B515-DE074BB156C3Q33867859-5DA5BA6B-74E3-4321-8319-49572E8D78F2Q33970149-8CF7327F-57F3-4854-AA91-C3376987B991Q34002120-2AB4946C-F2BA-4560-82F6-34D5B5E3805BQ34012962-CD6AA5E8-91D5-411E-85AE-17C889C744D1Q34028117-1EA27228-F3A4-49C5-A2FC-ACEE98A4C433Q34380438-717DFDEA-4337-4771-A4AC-A99492B0064FQ34382727-1D3877F0-B3DD-47D0-B927-3B27393A73E1Q34402163-39F2B895-36AF-4FA9-8AD9-B18C3B0E5475Q34450660-CD2449E1-3D50-4D7E-9C41-A363181B470AQ34557399-DB7F9D49-91B7-4622-AB1F-EF30C4A67F20Q34654088-6F3F34E8-143C-4397-81E9-4D42DAFE2E09Q34717513-4F971205-71A7-4DE9-B6B8-3FE85FFFEF84Q34733212-2460801D-4425-4443-9D6B-B6AE09D7A1E2Q35078737-B0F7E069-7A6B-44D1-842A-4438609CF317Q35080180-FFE2CDEF-C12D-4EFF-8C2C-860066799C3EQ35123146-6499E1E9-2374-4C78-91A7-A92B994C5CF0Q35942016-FF845349-003E-477F-891E-9B2B51C8F4D5Q35954035-AB9CC08F-0092-425F-A56A-85AEBAC0D68BQ36070574-6B9ED2AF-4D77-453C-A98E-33A92011B050Q36528511-AF19FB8D-228F-48EF-B44C-F1B2A8075431Q36561575-B1E49921-9FC6-46C3-8551-0E57AD442A06Q36568667-7DD9453E-91B2-4B3D-A396-9B9BA8F64450Q36580378-16EBF3D7-10B1-494A-8D12-6379853CF6D0Q37187411-F8FB0EB1-73F2-4E16-ACD8-6A0832A3E02FQ37329404-F0FF96E6-8330-466E-AAE0-4EFDC0B56032Q37370785-3B1B1A6A-ECDF-41CE-B8B4-2C4BC21814BAQ37407115-2F17E287-E1D8-4655-A595-B0045AB8705DQ37496567-B15D7DE1-9EE8-4F80-9049-55C6C5AE2D96Q37564060-56DE33EC-B789-4EA0-862F-A2FA1C264475
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
TP53 and liver carcinogenesis.
@ast
TP53 and liver carcinogenesis.
@en
type
label
TP53 and liver carcinogenesis.
@ast
TP53 and liver carcinogenesis.
@en
prefLabel
TP53 and liver carcinogenesis.
@ast
TP53 and liver carcinogenesis.
@en
P2093
P2860
P356
P1433
P1476
TP53 and liver carcinogenesis
@en
P2093
Curtis C Harris
Frank Staib
Lorne J Hofseth
Xin W Wang
P2860
P304
P356
10.1002/HUMU.10176
P50
P577
2003-03-01T00:00:00Z